Elliott Management’s Fortress Biotech FBIO Stock Holding History

Elliott Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-31,921	Closed	-$1.42M	–	81
2016 Q3	$1.42M	Sell	31,921 -39,726	-55%	-$1.69M	0.01%	74
2016 Q2	$2.89M	Sell	71,647 -24,092	-25%	-$1.12M	0.02%	79
2016 Q1	$4.45M	Sell	95,739 -30,849	-24%	-$1.3M	0.05%	58
2015 Q4	$5.3M	Sell	126,588 -46,056	-27%	-$1.93M	0.06%	64
2015 Q3	$6.73M	Sell	172,644 -76,108	-31%	-$3.56M	0.13%	47
2015 Q2	$12.5M	Hold	248,752	–	–	0.18%	37
2015 Q1	$14.4M	Hold	248,752	–	–	0.18%	39
2014 Q4	$9.1M	Hold	248,752	–	–	0.09%	63
2014 Q3	$7.84M	Hold	248,752	–	–	0.09%	61
2014 Q2	$6.42M	Hold	248,752	–	–	0.09%	56
2014 Q1	$7.39M	Hold	248,752	–	–	0.14%	35
2013 Q4	$9.78M	Hold	248,752	–	–	0.22%	31
2013 Q3	$26.2M	Hold	248,752	–	–	0.48%	24
2013 Q2	$32.1M	Buy	+248,752	New	+$36.7M	0.62%	21

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Elliott Management's FBIO Position: Q4 2016 in Review

Elliott Management sold out of Fortress Biotech (FBIO) in Q4 2016, closing a stake of 31,921 shares — an estimated $1.42M sold.

Elliott Management first reported a position in FBIO in Q2 2013 and held it in 14 quarters. The position peaked at $32.1M in Q2 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.

Elliott Management reported no remaining Fortress Biotech position as of Q4 2016 after selling out during the quarter.
Elliott Management sold 31,921 Fortress Biotech shares in Q4 2016, an estimated $1.42M.
Elliott Management first reported a position in Fortress Biotech in Q2 2013 and held it in 14 quarters.
Elliott Management's Fortress Biotech position peaked at $32.1M in Q2 2013.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.

Based on Elliott Management's 13F filing for Q4 2016, filed 14 Feb 2017.